Navigation Links
Challenges in Diagnosing Psychotic and Mood Disorders
Date:1/6/2009

MONTVALE, N.J., Jan. 6 /PRNewswire/ -- Mental illness is very troubling for patients. Often, they are misdiagnosed and therefore are medicated incorrectly and symptoms are not alleviated. As a clinician, it is imperative to recognize symptoms of mental illness, prescribe proper medication, and provide counseling and follow up to ensure patient compliance.

To make clinicians aware of the importance of proper diagnosis and management of psychotic and mood disorders, Current Psychiatry published a CME accredited supplement in December 2008, Diagnosing and managing psychotic and mood disorders. This multi-authored supplement discusses recognition of mood and psychotic disorders, the pros and cons of monotherapy and combination therapy, mechanisms of action of available medications, and tips to improve patient compliance.

Current Psychiatry, an indexed and peer-reviewed journal distributed to 38,000 psychiatrists, has published Diagnosing and managing psychotic and mood disorders with support from AstraZeneca. It is available in print and can be found online at: http://www.currentpsychiatry.com/article_pages.asp?AID=7020

Current Psychiatry is published by Dowden Health Media, a Division of Lebhar-Friedman, Inc. Dowden Health Media is a full-service healthcare communications company that specializes in high-quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine, and obstetrics/gynecology.


'/>"/>
SOURCE Dowden Health Media
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ADA Challenges Marylanders to Step Out to Fight Diabetes Epidemic
2. Braun Challenges Business School Talent To Create A Buzz
3. Genetics Hold Promise, Challenges for Cancer Care
4. Planning for 2020: increasing elderly population poses huge challenges in cancer care
5. Lunch Lady Challenges Schools, Families to Make Kids Nutrition a Priority
6. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
7. Yoplait(R) Challenges One Million Americans to Pledge to Their Breast Health
8. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
9. Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House
10. Math battling cancer, deciding lifes challenges lead list as INFORMS meet in Seattle
11. Catholic Charities USA to Release Report on November 15th that Shows Challenges Facing Americas Poor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology: